Executive Director, Evidence Synthesis & Statistics

RTI Health Solutions (RTI-HS), a wholly owned subsidiary of RTI International, is an independent and internationally recognized research organization. With offices in the US, UK, Spain, France, and Sweden, we provide healthcare consulting and research expertise to optimize decision making for pharmaceutical, biotechnology, and medical device products across the development and marketing lifecycle. Clients rely on our expertise, quality standards, and integrity to guide their product development and regulatory and market access strategies. Our various practice areas include Value, Access, and HEOR; Patient-Centered and Outcomes Research; Epidemiology and Biostatistics; Medical Communications; Global Business Operations; and Strategic Consulting and Growth

The Evidence Synthesis & Statistics (ESS) practice plays an important role in helping clients evaluate the clinical, humanistic, and economic value of healthcare interventions. The team delivers evidence synthesis, indirect treatment comparisons, network meta-analysis, advanced statistical analysis, and strategic evidence planning to support HTA, regulatory, payer, market access, and evolving Joint Clinical Assessment (JCA) decision-making globally.

We are seeking an accomplished scientific leader to join our team.  This individual will provide strategic, scientific, and operational leadership for evidence synthesis and statistical services while remaining hands-on in the delivery of complex client work.

• →Lead business development activities, including identifying opportunities, developing proposals, supporting client presentations and scientific meetings, and contributing senior scientific insight throughout the sales process
• →Partner with commercial and scientific leaders across RTI-HS to expand the visibility and position of the HTA Statistics capability
• →Act as a senior client contact, building long-term relationships and providing strategic and methodological input across engagements
• →Monitor industry trends, HTA, payer, and evolving JCA evidence requirements, and competitive landscape to inform service development

• Build, mentor, coach, and develop a high-performing team of evidence synthesis statisticians
• Oversee project delivery to ensure scientific rigour, client satisfaction and financial performance
• Lead complex projects and portfolios, ensuring alignment to timelines, budgets, quality standards, and client expectations
• Ensure appropriate tools, processes, and methodological standards are in place and continuously improved
• Foster collaboration across HEOR, RWE, Epidemiology, Market Access and Biostatistics to deliver integrated solutions

• Represent RTI-HS through conference presentations, publications, workshops and webinars
• Build the external scientific profile of the HTA Statistics capability through active engagement with the research and HTA community including JCA
• Contribute to the advancement of evidence synthesis methodologies, promoting innovative approaches that leverage AI, automation, advanced analytics, and other emerging technologies where appropriate
• Support development of internal best practices, methodological guidance and reusable intellectual capital

• Advanced degree (PhD, DrPH, ScD, MD, PharmD, or equivalent) in epidemiology, health economics, biostatistics, public health, pharmacy, or a related scientific discipline, plus a minimum of 12+ years of relevant experience
• Significant relevant experience, leading advanced quantitative evidence synthesis. HTA Statistics and statistical projects within a pharmaceutical company, CRO, consulting organisation, or academic research environment.
• activities within a pharmaceutical company, CRO, consulting organisation, or academic research environment 
• Deep expertise in network meta-analysis, other indirect treatment comparison methods, advanced statistical methods, and broader evidence generation strategy 
• Demonstrated success leading multidisciplinary project teams and managing complex client engagements 
• Proven business development experience, including proposal leadership, client relationship management and revenue generation 
• Strong expertise across advanced statistical and evidence synthesis methodologies, including Bayesian approaches, network meta-analysis, other indirect treatment comparisons (e.g. MAIC), survival analysis and health utility analysis (e.g. EQ-5D) 
• Familiarity with emerging methods and approaches, such as target trial emulation and evolving evidence synthesis techniques 
• Advanced programming skills in R and/or STATA 
• Strong understanding of global HTA, payer, and evolving JCA evidence requirements, and the role of evidence synthesis across the product lifecycle 
• Exceptional communication and presentation skills, with the ability to engage scientific, commercial and executive audiences